Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study

Systemic sclerosis (SSc) is a connective tissue disease characterized by immune-system alterations, fibrosis involving the skin and internal organs and diffuse microangiopathy. Pulmonary arterial hypertension (PAH) is a severe complication of SSc affecting about 10–15% of the patients and it is a leading cause of mortality. Due to the devastating nature of SSc-PAH, there is a clear need to systematically adopt appropriate screening programs. Nail fold videocapillaroscopy (NVC) studies have shown a more severe peripheral microvascular dysfunction in SSc patients with PAH suggesting that abnormalities in peripheral microcirculation may correlate with pulmonary microangiopathy. This is a cross-sectional study involving four tertiary University Rheumatology Units in the Center-North of Italy. Seventy patients, 35 adults with SSc and PAH confirmed by RHC (F/M 34/1; median age 65.2 ± 8.9 SD yrs), and 35 SSc patients without PAH were enrolled (F/M 3471; median age 63.3 ± 10.3 SD yrs). Clinical, laboratoristic and instrumental data were collected and NVC was performed in all patient. Specific NVC parameters were evaluated and a semi-quantitative rating scale was adopted to score these changes. Finally, patients were distributed into the suitable NVC pattern belonging to the scleroderma pattern. Our aim was to compare the peripheral microangiopathy changes in SSc patients with and without PAH, and to investigate the relationship between NVC findings and the main hemodynamic parameters of pulmonary vasculopathy. Patients with SSc-PAH+ showed a significant higher frequency of interstitial lung disease (ILD). No significant differences regarding clinical and laboratoristic parameters were observed. NVC abnormalities, avascular areas were more frequent in SSc patients with PAH, respect to those without (p = 0.03), and capillary density was significantly lower when considering grade 3 (p = 0.02). A higher NVC semiquantitative mean was found in SSc-PAH+ patients and a greater rate of the “late” pattern was detected in SSc-PAH+ subjects in respect to PAH- (57.1% vs. 25.7%) (p = 0.03). A significant correlations between pulmonary pressure values (sPAP by TTE and mPAP by RHC) and the capillary density (Spearman's rho 0.35, p = 0.04 for both). Our findings provide additional evidence to the literature data, confirming that a higher degree of peripheral nailfold microangiopathy is more common in SSc-PAH patients, and further strengthening the concept that NVC changes may run parallel with similar abnormalities inside pulmonary microcirculation.

[1]  L. Magnani,et al.  Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology , 2021, The Journal of Rheumatology.

[2]  K. Zakrzewska,et al.  Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis. , 2021, Journal of autoimmunity.

[3]  C. Bruni,et al.  The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients , 2021, Pharmaceuticals.

[4]  P. Sarafidis,et al.  Nailfold Capillaroscopy in Systemic Sclerosis Patients with and without Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.

[5]  M. Vonk,et al.  Change of the microvascularization in systemic sclerosis, a matter of air. , 2021, Best practice & research. Clinical rheumatology.

[6]  F. Cacciapaglia,et al.  Pulmonary arterial hypertension: guidelines and unmet clinical needs. , 2021, Reumatismo.

[7]  G. Giannakoulas,et al.  Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study , 2020, Respiratory Research.

[8]  G. Kitas,et al.  Nailfold videocapillaroscopy: a novel possible surrogate marker for the evaluation of peripheral microangiopathy in pulmonary arterial hypertension , 2020, Scandinavian journal of rheumatology.

[9]  R. Caporali,et al.  High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis , 2020, Arthritis Research & Therapy.

[10]  A. Iagnocco,et al.  Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. , 2020, Autoimmunity reviews.

[11]  M. Cutolo,et al.  Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. , 2019, Rheumatology.

[12]  M. Humbert,et al.  Screening for pulmonary arterial hypertension in systemic sclerosis , 2019, European Respiratory Review.

[13]  Y. Liu,et al.  Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta‐analysis , 2018, Internal medicine journal.

[14]  M. Biase,et al.  Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. , 2017, Microvascular research.

[15]  C. Denton,et al.  SYSTEMIC SCLEROSIS , 2008 .

[16]  M. Boubaya,et al.  Mapping and predicting mortality from systemic sclerosis , 2017, Annals of the rheumatic diseases.

[17]  M. Cutolo,et al.  Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. , 2017, Seminars in arthritis and rheumatism.

[18]  J. Varga,et al.  Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities , 2017 .

[19]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[20]  F. Iannone,et al.  Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases , 2015, Internal and Emergency Medicine.

[21]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[22]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[23]  P. Boracchi,et al.  Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. , 2013, Microvascular research.

[24]  C. Vizza,et al.  Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. , 2013, Rheumatology.

[25]  L. Frumkin The Pharmacological Treatment of Pulmonary Arterial Hypertension , 2012, Pharmacological Reviews.

[26]  W. Grassi,et al.  Interreader Reliability in Assessment of Nailfold Capillary Abnormalities by Beginners: Pilot Study of an Intensive Videocapillaroscopy Training Program , 2012, The Journal of Rheumatology.

[27]  Y. Allanore,et al.  Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. , 2012, Rheumatology.

[28]  M. Cutolo,et al.  Timing of transition between capillaroscopic patterns in systemic sclerosis. , 2012, Arthritis and rheumatism.

[29]  M. Humbert,et al.  Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. , 2011, Arthritis and rheumatism.

[30]  J. Stamm,et al.  Overview of current therapeutic approaches for pulmonary hypertension , 2011, Pulmonary circulation.

[31]  E. Hachulla,et al.  Diagnosis and Classification of Systemic Sclerosis , 2011, Clinical reviews in allergy & immunology.

[32]  A. Silman,et al.  Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .

[33]  E. Feierl,et al.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.

[34]  A. Firth,et al.  Idiopathic pulmonary arterial hypertension , 2010, Disease Models & Mechanisms.

[35]  D. Playford,et al.  Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis , 2009, Internal medicine journal.

[36]  P. Postmus,et al.  Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis , 2008, Annals of the rheumatic diseases.

[37]  F. Schmidt Meta-Analysis , 2008 .

[38]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[39]  M. Cutolo,et al.  New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review. , 2019, The Journal of rheumatology.

[40]  A. Herrick,et al.  Digital ulcers in systemic sclerosis , 2017, Rheumatology.

[41]  Teresa Foo,et al.  : SYSTEMATIC LITERATURE REVIEW , 2004 .